期刊文献+

临床药师对泛耐药鲍氏不动杆菌重症肺炎药学监护探讨 被引量:2

Clinical pharmacists participation to pharmaceutical care of severe pneumonia caused by pandrug-resistant Acinetobacter baumannii
原文传递
导出
摘要 目的探讨临床药师参与重症肺炎患者药学监护的方法和作用,促进医院抗菌药物的合理应用。方法以2014年1月1例泛耐药鲍氏不动杆菌重症肺炎患者治疗为例,临床药师从制定个体化用药方案、提供用药依据、监测药物不良反应等,提供全程的药学监护,应用超常规剂量的替加环素治疗,并进行临床效果评价。结果临床药师积极参与药物治疗过程,对患者实施合理的药学监护,患者体温、血常规、C-反应蛋白等显著好转,两下肺病灶较前显著吸收,痰培养鲍氏不动杆菌为阴性,取得了满意的治疗效果。结论对重症肺炎患者开展药学监护非常必要,保证了患者治疗的安全性和有效性,有利于临床合理用药及医院整体用药水平的提高。 OBJECTIVE To discuss the measures and effectiveness of the clinical pharmacists participation to the pharmaceutical care of the patients with severe pneumonia so as to promote the reasonable use of antibiotics . METHODS In Jan ,2014 ,1 patient with severe pneumonia caused by pandrug‐resistant Acinetobacter baumannii was recruited as the study object ,then the clinical pharmacists offered the whole process pharmaceutical care by formulating the individual mediation program ,providing medication basis ,and monitoring the adverse events of drugs ,the patient was treated with super‐normal dose of tigecycline , and the clinical effect was evaluated . RESULTS The clinical pharmacist took an active part in the drug therapy ,the reasonable pharmaceutical care was carried out for the patient ;the body temperature ,blood routine ,and C‐reactive protein were significantly im‐proved ,two lung lesions were remarkably absorbed ,the sputum was cultured negative for A .baumannii ,and the therapeutic effect was satisfactory .CONCLUSION It is very necessary to carry out the pharmaceutical care for the patients with severe pneumonia ,the safety and effectiveness of the treatment have been ensured ,which is condu‐cive to the reasonable use of antibiotics and the improvement of overall level of medication .
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2014年第24期6102-6104,共3页 Chinese Journal of Nosocomiology
基金 河南省医学科技基金资助项目(201304056)
关键词 泛耐药鲍氏不动杆菌 重症肺炎 替加环素 药学监护 Pandrug-resistant Acinetobacter baumannii Severe pneumonia Tigecycline Pharmaceutical care
  • 相关文献

参考文献8

  • 1Bergallo C,Jasovich A,Teglia O,et al. Safety and efficacy of intravenous tigeeycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin[J]. Diagn Microbiol In- feet Dis,2009,63(1) :52-61.
  • 2Neuner EA, Yeh JY, Hall GS, et al. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections[J]. Diagnostic Microbiology and Infectious Dis- ease, 2011,69 (4) : 357.
  • 3章白苓,桂炳东,胡晓彦,胡龙华,贾坤如.多重耐药鲍曼不动杆菌对替加环素等15种抗菌药物的耐药性分析[J].临床检验杂志,2011,29(7):553-554. 被引量:19
  • 4史煜波,董燕.替加环素与多粘菌素B对泛耐药鲍曼不动杆菌体外研究[J].中国微生物杂志,2010,22(9):825.
  • 5Crandon JL, Kim A, Nieolau DP. Comparison of tigecyeline penetration into the epithelial lining fluid of infected and unin- fected murine lungs[J]. J Antimicrob Chemother, 2009, 64 (4) :837-839.
  • 6Freire AT, Melnyk V, Kim MJ, et al. 311 Study Group. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia[J]. Diagn Micro- hlnl Infect Dis. 2010.68(2), 140-151.
  • 7赵霞,王力红,张京利,马文晖,赵会杰.多药耐药鲍氏不动杆菌的同源性鉴定与控制[J].中华医院感染学杂志,2012,22(12):2492-2494. 被引量:85
  • 8Burkhardt O, Rauch K, Kaever V, et al. Tigecycline possibly underdosed for the treatment of pneumonia., a pharmacoki- netic viewpoint[J]. Int J Antimicrob Agents, 2009,34 (1) : 101-102.

二级参考文献10

共引文献102

同被引文献17

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部